Who is the manufacturer of Negative Pressure Wound Therapy Device (V-Move, V-Grand)?

Med Way, Inc. filed the 510(k) submission for Negative Pressure Wound Therapy Device (V-Move, V-Grand) (K241023).

What is the FDA product code for Negative Pressure Wound Therapy Device (V-Move, V-Grand)?

OMP. It is classified under 21 CFR 878.4780 as a Class 2 device in the General, Plastic Surgery panel.

What is the regulatory pathway for Negative Pressure Wound Therapy Device (V-Move, V-Grand)?

510(k) clearance (submission type: Traditional).

Who can help prepare an FDA 510(k) submission like Negative Pressure Wound Therapy Device (V-Move, V-Grand)?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

Negative Pressure Wound Therapy Device (V-Move, V-Grand)

K241023 · Med Way, Inc. · OMP · Aug 19, 2024 · General, Plastic Surgery

Device Facts

Record ID	K241023
Device Name	Negative Pressure Wound Therapy Device (V-Move, V-Grand)
Applicant	Med Way, Inc.
Product Code	OMP · General, Plastic Surgery
Decision Date	Aug 19, 2024
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 878.4780
Device Class	Class 2
Attributes	Therapeutic

Intended Use

The Negative Pressure Wound Therapy Device is indicated for wound management via the application of negative pressure to the wound by the removal of wound exudate, infectious materials, and tissue debris from the wound bed. The Negative Pressure Wound Therapy Device is indicated for the following wound types: chronic, acute, traumatic, subacute, and dehisced wounds, partial-thickness burns, ulcers (such as diabetic or pressure), flaps, and grafts.

Device Story

Portable, battery-powered suction pump; generates negative pressure (50-200 mmHg for V-Move; 0-200 mmHg for V-Grand) to remove wound exudate, infectious material, and debris. Used in professional medical facilities by clinicians. System includes pump, collection canister (300cc-1000cc), and tubing; compatible with foam dressing kits. Operates in continuous or intermittent modes; intermittent mode alternates pressure/rest cycles. Clinicians program pressure settings and therapy duration to manage wound healing. Benefits include exudate removal and maintenance of negative pressure environment to support wound closure.

Clinical Evidence

No clinical data. Substantial equivalence supported by bench testing, including safety, electromagnetic compatibility (EMC), and functional performance testing. Device complies with ANSI AAMI ES60601-1 and IEC 60601-1-2 standards.

Technological Characteristics

Portable, rechargeable lithium battery-powered suction pump. Materials: PVC tubing. Non-sterile (pump/canister). Pressure range: 50-200 mmHg (V-Move), 0-200 mmHg (V-Grand). Connectivity: Standalone. Standards: ANSI AAMI ES60601-1, IEC 60601-1-2. Software-controlled pressure regulation.

Indications for Use

Indicated for wound management in patients with chronic, acute, traumatic, subacute, and dehisced wounds, partial-thickness burns, diabetic/neuropathic/pressure ulcers, flaps, and grafts. Contraindicated for exposed vessels, organs, nerves, anastomotic sites, exposed arteries/veins, non-enteric fistulas, untreated osteomyelitis, malignancy in wound, excess necrotic tissue with eschar, wounds too large/deep for dressing, patients unable to be followed by medical professional, allergy to urethane dressings/adhesives, or use of topical products requiring frequent dressing changes.

Regulatory Classification

Identification

A powered suction pump is a portable, AC-powered or compressed air-powered device intended to be used to remove infectious materials from wounds or fluids from a patient's airway or respiratory support system. The device may be used during surgery in the operating room or at the patient's bedside. The device may include a microbial filter.

Predicate Devices

EXTRICARE (K132225)

Reference Devices

VCare 1000-300S System (K162159)

Related Devices

K213906 — extriCARE 1000 Negative Pressure Wound Therapy System · Alleva Medical, Ltd. · Mar 8, 2023
K161599 — UNO Negative Pressure Wound Therapy System · Genadyne Biotechnologies, Inc. · Apr 6, 2017
K221223 — extriCARE® 3000 Negative Wound Pressure Therapy System · Alleva Medical Devices · Feb 9, 2023
K241061 — VERSA Negative Pressure Wound Therapy System (VCMPP-100) · Cork Medical · Aug 21, 2024
K132225 — EXTRICARE · Devon Medical, Inc. · May 15, 2014

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. August 19, 2024 Med Way Inc. % Charles Mack Principal Engineer Irc 2950 E Lindrick Drive Chandler, Arizona 85249 Re: K241023 Trade/Device Name: Negative Pressure Wound Therapy Device (V-Move, V-Grand) Regulation Number: 21 CFR 878.4780 Regulation Name: Powered suction pump Regulatory Class: Class II Product Code: OMP Dated: March 23, 2024 Received: April 15, 2024 Dear Charles Mack: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. {2}------------------------------------------------ For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, # Yu-chieh Chiu -S Yu-Chieh Chiu, Ph.D. Assistant Director DHT4B: Division of Plastic and Reconstructive Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ #### Indications for Use 510(k) Number (if known) K241023 Device Name Negative Pressure Wound Therapy Device (V-Move, V-Grand) Indications for Use (Describe) The Negative Pressure Wound Therapy Device is indicated for wound management via the application of negative pressure to the wound by the removal of wound exudate, infectious materials, and tissue debris from the wound bed. The Negative Pressure Wound Therapy Device is indicated for the following wound types: chronic, acute, traumatic, subacute, and dehisced wounds, partial-thickness burns, ulcers (such as diabetic or pressure), flaps, and grafts. | Type of Use (Select one or both, as applicable) | | | | | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------|-----------------------------------------|---------------------------------------------|--------------------------| | <div style="display:flex; align-items:center;"> <tr><td>Prescription Use (Part 21 CFR 801 Subpart D)</td><td><input checked="true" type="checkbox"/></td></tr> <tr><td>Over-The-Counter Use (21 CFR 801 Subpart C)</td><td><input type="checkbox"/></td></tr> </div> | Prescription Use (Part 21 CFR 801 Subpart D) | <input checked="true" type="checkbox"/> | Over-The-Counter Use (21 CFR 801 Subpart C) | <input type="checkbox"/> | | Prescription Use (Part 21 CFR 801 Subpart D) | <input checked="true" type="checkbox"/> | | | | | Over-The-Counter Use (21 CFR 801 Subpart C) | <input type="checkbox"/> | | | | #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {4}------------------------------------------------ ## 510(k) SUMMARY AS RÉQUIRED BY 21CFR807.92(c) | Preparation Date: | August 19, 2024 | |----------------------------------|--------------------------------------------------------------------------------------------------| | Manufacturer's Name and Address: | Med Way Inc. 1650 Horizon Pkwy NE, Suite 450, Buford, GA, USA 30518 Tel: (888) 563-3929 | | Corresponding Official: | Charles Mack | | Telephone Number: | 931-625-4938 | | Email Address: | charliemack@irc-us.com | | Trade Name: | Negative Pressure Wound Therapy Device Model: V-Move, V-Grand | | Common Name(s): | negative pressure wound therapy powered suction pump | | Regulation Name(s): | Powered suction pump | | Regulation Number(s): | 21CFR878.4780 | | Primary Product Code: | OMP | | Device Class: | Class II | | Predicate Device: | K132225 | | Trade Name: | EXTRICARE | | Common Name: | negative pressure wound therapy powered suction pump | | Regulation Number(s): | 21CFR878.4780 | | Product Code: | OMP | {5}------------------------------------------------ ### Device Description: The Negative Pressure Wound Therapy Device is a portable, rechargeable, battery powered pump capable of delivering bespoke continuous and/or intermittent negative pressure intended to allow wound management by draining and removing wound exudates, infectious material, and tissue debris from the wound bed. The Negative Pressure Wound Device is packaged and provided with the following components: Negative Pressure Wound Therapy Pump and Collection Canister. Patients with chronic, acute, traumatic, subacute, and dehisced wounds, partial-thickness burns, diabetic ulcers, neuropathic ulcers, pressure ulcers, flaps, and grafts may benefit from this system. The Negative Pressure Wound Therapy Device used with wound dressings can produce a negative pressure environment in either intermittent or continuous mode. This allows the user to program the specific pressure ranging from 50mmHg to 200mmHg (V-Move) and 0 to 200 mmHg (V-Grand). In intermittent mode, the pump will alternate between applying pressure for 5 continuous minutes and reducing pressure to 0 for 2 minutes for V-Move. In intermittent mode, therapy pressure, operating time, and interval time can be adjusted for V-Grand. The Negative Pressure Wound Therapy Device is compatible with the Longterm NPWT Foam Dressing Kit (K211571). The device is used in professional medical facilities. The Negative Pressure Wound Therapy pump accessories that are included in this 510(k) submission and will be commercialized separately are the following: 300cc Collection Canister 500cc Collection Canister 1000cc Collection Canister {6}------------------------------------------------ #### Indications for Use The Negative Pressure Wound Therapy Device is indicated for wound management via the application of negative pressure to the wound by the removal of wound exudate, infectious materials, and tissue debris from the wound bed. The Negative Pressure Wound Therapy Device is indicated for the following wound types: chronic, acute, traumatic, subacute, and dehisced wounds, partial-thickness burns, ulcers (such as diabetic or pressure), flaps, and grafts. {7}------------------------------------------------ K241023 Page 4 of 6 | Item | Subject Device | Predicate Device | Reference Device | Comment | |--------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------| | 510(k) | K241023 | K132225 | K162159 | - | | Device | Negative Pressure Wound Therapy Device | Negative Pressure Wound Therapy System | VCare 1000-300S System | - | | Model | V-Move, V-Grand | extriCARE 3600 | VCare 1000-300S Pump | - | | Applicant | MED WAY INC. | Devin Medical, Inc. | VR Medical Technology Company, Ltd. | - | | Product code | OMP | OMP | OMP | - | | Regulation Number | 878.4780 | 878.4780 | 878.4780 | - | | Indication for Use | The Negative Pressure Wound Therapy Device is indicated for wound management via the application of negative pressure to the wound by the removal of wound exudate, infectious materials, and tissue debris from the wound bed. The Negative Pressure Wound Therapy Device is indicated for the following wound types: chronic, acute, traumatic, subacute and dehisced wounds, partial- thickness burns, ulcers (such as diabetic or pressure), flaps and grafts. | The extriCARE 3600 Negative Pressure Wound Therapy System is indicated for wound management via the application of negative pressure to the wound by the removal of wound exudate, infectious materials, and tissue debris from the wound bed. The extriCARE 3600 Negative Pressure Wound Therapy System is indicated for the following wound types: chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, ulcers (such as diabetic or pressure), flaps and grafts. | The VR Medical VCare 1000- 300S Negative Pressure Wound Therapy System is an integrated wound management system, indicated for wound management via the application of negative pressure to the wound, in order for the removal of fluids, including wound exudates, irrigation fluids, body fluids and infectious materials. The system is intended for patients with chronic, acute, traumatic, subacute and dehisced wounds, partial- thickness burns, ulcers (such as diabetic or pressure), flaps and grafts. | Identical Note 1 | | Contraindications | - Exposed vessels, organs, or nerves. - Anastomotic sites. - Exposed arteries or veins in a wound. - Fistulas, unexplored or non-enteric. - Untreated osteomyelitis. - Malignancy in the wound. - Excess amount of necrotic tissue with eschar. - Wounds which are too large or too deep to be accommodated by the dressing. - Inability to be followed by a medical professional or to keep scheduled appointments. - Allergy to urethane dressings and adhesives. - Use of topical products which must be applied more frequently than the dressing change schedule allows | Exposed vessels, organs, or nerves. Anastomotic sites. Exposed arteries or veins in a wound. Fistulas, unexplored or non-enteric. Untreated osteomyelitis. Malignancy in the wound. Excess amount of necrotic tissue with eschar. Wounds which are too large or too deep to be accommodated by the dressing. Inability to be followed by a medical professional or to keep scheduled appointments. Allergy to urethane dressings and adhesives. Use of topical products which must be applied more frequently than the dressing change schedule allows | Exposed vessels, organs, or nerves. Anastomotic sites. Exposed arteries or veins in a wound. Fistulas, unexplored or non-enteric. Untreated osteomyelitis. Malignancy in the wound. Excess amount of necrotic tissue with eschar. Wounds which are too large or too deep to be accommodated by the dressing. Inability to be followed by a medical professional or to keep scheduled appointments. Allergy to urethane dressings and adhesives. Use of topical products which must be applied more frequently than the dressing change schedule allows | Identical | | Item | Subject Device | Predicate Device | Reference Device | Comment | | Principle of Operation | A vacuum pump generates vacuum. A collection canister is connected to the vacuum pump, and a tubing connecting the wound dressing and the canister brings wound exudate | A vacuum pump generates vacuum. A collection canister is connected to the vacuum pump, and a tubing connecting the wound dressing and the canister brings wound exudate | A vacuum pump generates vacuum. A collection canister is connected to the vacuum pump, and a tubing connecting the wound dressing and the canister brings wound exudate | Identical | | Vacuum mode | Continuous and Intermittent | Continuous and Intermittent | Continuous and Intermittent | Identical | | Negative Pressure | 50~200 mmHg (V-Move) 0~200 mmHg (V-Grand) | 40~200 mmHg | 20~200 mmHg | Note 2 | | Canister | 300cc, 500cc (V-Move) 500cc, 1000cc (V-Grand) | 400cc, 1000cc | 140, 400, 600cc | Note 2 | | Prescription Use | Yes | Yes | Yes | Identical | | Sterility | Non-sterile (exclude dressing) | Non-sterile (exclude dressing) | Non-sterile (exclude dressing) | Identical | | Weight | 1.5 lbs (0.7kg) for V-Move; 8.1 lbs (3.7kg) for V-Grand | 2.87 lbs (1.3kg) | 0.51 lbs (0.23kg) | Note 3 | | User Life | Indefinite, with routine servicing and repair | Indefinite, with routine servicing and repair | Indefinite, with routine servicing and repair | Identical | | Energy source | AC and Battery | AC and Battery | AC and Battery | Identical | | Negative Pressure Tubing | PVC | PVC | PVC | Identical | | Battery | Lithium battery | Lithium battery | Lithium battery | Identical | {8}------------------------------------------------ # K241023 Page 5 of 6 {9}------------------------------------------------ #### Testing Non-clinical tests were conducted to verify that the proposed devices met all design specifications as was Substantially Equivalent (SE) to the predicate device. The test results demonstrated that the proposed devices comply with the following standards: #### Safety and EMC - ANSI AAMI ES60601-1:2005/(R)2012 & A1:2012, C1:2009/(R)2012 & A2:2010/(R)2012 (Cons. Text) [Incl. AMD2:2021] Medical electrical equipment - Part 1: General requirements for basic safety and essential performance (IEC 60601-1:2005, MOD) [Including Amendment 2 (2021)] - IEC60601-1-2 Edition 4.1 2020-09 CONSOLIDATED VERSION Medical electrical . equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests #### Biocompatibility The Pump and the Cannister are not tissue contacting. No biocompatibility test submitted. #### Performance To ensure the performance of subject device meet the design input, a series of bench tests were conducted which including safety test, environmental test, device performance test, function test etc. #### Software The software validation was conducted according to the FDA guidance "Content of Premarket Submissions for Device Software Functions". Testing concluded that the subject device met the requirement. #### Clinical Study: No clinical testing was required to support substantial equivalence #### Conclusion: In accordance with the Federal Food, Drug and Cosmetic Act and 21 CFR Part 807, and based on the information provided in this pre-market notification, the subject device is as safe and as effective as and substantially equivalent to the predicate devices as described herein.